Libella Gene Therapeutics
Summary
CEO
William AndrewsArea of work
Libella aims to complete a human trial using AAV/hTERT to treat or significantly improve Alzheimer disease using telomerase gene therapy.
Contact Details
Address
2021 Vanesta Place Suite D, Manhattan, KS 66503, USA
E-mail (# = @)
Not available
Website
https://www.libellagenetherapeutics.com/